IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Horizon Pharma Inc

CUSIP: 44047TAD1 | 2 institutional holders

Quarters

Q1 2019Q4 2018Q3 2018Q2 2018Q1 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2019

L & S Advisors Inc250,000
0.0% of portfolio›$257
StyleTurnoverLocationFiled
L & S Advisors Inc
250,000$2570.0%CoreHighLos Angeles, CA2019-05-14